+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Endoscopic Retrograde Cholangiopancreatography/ERCP Market Size, Share & Industry Trends Analysis Report By Procedure, By Product, By Endotherapy Devices Type, By End User, By Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 121 Pages
  • April 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5600793
The Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market is expected to witness market growth of 9.9% CAGR during the forecast period (2022-2028).

The pancreatic ducts connect the pancreas to the duodenum and transport pancreatic juice. The tubes that convey bile from the liver to the gallbladder and duodenum are called bile ducts. Whenever infection, gallstones, chronic pancreatitis, acute pancreatitis, pancreatic pseudocysts, malignancies of the biliary tract and pancreas, and other conditions cause the bile or pancreatic ducts to constrict or obstruct, an ERCP surgery is required to prevent further health damage.

Endoscopy is often used in ERCP to locate the minor and major papillae. To detect the biliary and pancreatic ductal systems, cannulation is performed and a contrast agent is injected. Diagnostic techniques such as biopsy, cholangiopancreatoscopy, or brush cytology can be performed during an ERCP.

Antibiotic prophylaxis is sometimes not recommended before an ERCP surgery. Moreover, it is appropriate for patients who've had a liver transplant or biliary blockage. Medications should be maintained after ERCP if biliary drainage is insufficient, and biliary flora, particularly enterococci and gram-negative organisms, should be covered.

The high growth in this regional Market can be attributed to Japan's well-developed healthcare system, which includes universal health insurance coverage. Countries such as China and India focused on improving healthcare facilities to treat massive numbers of patients with severe disorders, such as cancer and tumors.

Moreover, demand for endoscopic retrograde cholangiopancreatography (ECRP) devices is also predicted to rise due to an increase in the number of endoscopic retrograde cholangiopancreatography (ECRP) device manufacturers.

The China Market dominated the Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $171.9 million by 2028. The Japan Market is experiencing a CAGR of 9.2% during (2022-2028). Additionally, The India Market is expected to exhibit a CAGR of 10.5% during (2022-2028).

Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.

Scope of the Study


Market Segments Covered in the Report:


By Procedure
  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting & Dilation
By Product
  • Endotherapy Devices
    • Stents & Sphincterotomes
    • Catheters
    • Lithotripter
    • Cannulas
    • Forceps
    • Snares
    • Guiding Wires
    • Balloons
    • Others
  • Endoscopes
  • Visualization Systems
  • Energy Devices
  • Others
By End User
  • Hospitals
  • Ambulatory Surgery Centres & Clinics
  • Others

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players


List of Companies Profiled in the Report:

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Steris PLC
  • Johnson & Johnson
  • Braun Melsungen AG
  • ConMed Corporation
  • Medtronic PLC
  • Karl Storz SE & Co. KG

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market, by Procedure
1.4.2 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market, by Product
1.4.3 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market, by End User
1.4.4 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Endoscopic Retrograde Cholangiopancreatography/ERCP Market
Chapter 4. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Procedure
4.1 Asia Pacific Biliary Sphincterotomy Market by Country
4.2 Asia Pacific Biliary Stenting Market by Country
4.3 Asia Pacific Biliary Dialatation Market by Country
4.4 Asia Pacific Pancreatic Sphincterotomy Market by Country
4.5 Asia Pacific Pancreatic Duct Stenting & Dilation Market by Country
Chapter 5. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Product
5.1 Asia Pacific Endotherapy Devices Market by Country
5.2 Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
5.2.1 Asia Pacific Stents & Sphincterotomes Market by Country
5.2.2 Asia Pacific Catheters Market by Country
5.2.3 Asia Pacific Lithotripter Market by Country
5.2.4 Asia Pacific Cannulas Market by Country
5.2.5 Asia Pacific Forceps Market by Country
5.2.6 Asia Pacific Snares Market by Country
5.2.7 Asia Pacific Guiding Wires Market by Country
5.2.8 Asia Pacific Balloons Market by Country
5.2.9 Asia Pacific Others Market by Country
5.3 Asia Pacific Endoscopes Market by Country
5.4 Asia Pacific Visualization Systems Market by Country
5.5 Asia Pacific Energy Devices Market by Country
5.6 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by End User
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Ambulatory Surgery Centres & Clinics Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Country
7.1 China Endoscopic Retrograde Cholangiopancreatography Market
7.1.1 China Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.1.2 China Endoscopic Retrograde Cholangiopancreatography Market by Product
7.1.2.1 China Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.1.3 China Endoscopic Retrograde Cholangiopancreatography Market by End User
7.2 Japan Endoscopic Retrograde Cholangiopancreatography Market
7.2.1 Japan Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.2.2 Japan Endoscopic Retrograde Cholangiopancreatography Market by Product
7.2.2.1 Japan Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.2.3 Japan Endoscopic Retrograde Cholangiopancreatography Market by End User
7.3 India Endoscopic Retrograde Cholangiopancreatography Market
7.3.1 India Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.3.2 India Endoscopic Retrograde Cholangiopancreatography Market by Product
7.3.2.1 India Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.3.3 India Endoscopic Retrograde Cholangiopancreatography Market by End User
7.4 South Korea Endoscopic Retrograde Cholangiopancreatography Market
7.4.1 South Korea Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.4.2 South Korea Endoscopic Retrograde Cholangiopancreatography Market by Product
7.4.2.1 South Korea Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.4.3 South Korea Endoscopic Retrograde Cholangiopancreatography Market by End User
7.5 Singapore Endoscopic Retrograde Cholangiopancreatography Market
7.5.1 Singapore Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.5.2 Singapore Endoscopic Retrograde Cholangiopancreatography Market by Product
7.5.2.1 Singapore Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.5.3 Singapore Endoscopic Retrograde Cholangiopancreatography Market by End User
7.6 Malaysia Endoscopic Retrograde Cholangiopancreatography Market
7.6.1 Malaysia Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.6.2 Malaysia Endoscopic Retrograde Cholangiopancreatography Market by Product
7.6.2.1 Malaysia Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.6.3 Malaysia Endoscopic Retrograde Cholangiopancreatography Market by End User
7.7 Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market
7.7.1 Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Procedure
7.7.2 Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Product
7.7.2.1 Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Endotherapy Devices Type
7.7.3 Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by End User
Chapter 8. Company Profiles
8.1 Olympus Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 Fujifilm Holdings Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Ambu A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment & Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Approvals and Trials:
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Steris PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Johnson & Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 B. Braun Melsungen AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 ConMed Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Medtronic PLC
8.9.1 Company overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Karl Storz SE & Co. KG
8.10.1 Company Overview

Companies Mentioned

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Steris PLC
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • ConMed Corporation
  • Medtronic PLC
  • Karl Storz SE & Co. KG

Methodology

Loading
LOADING...